Evidence map›Paper›PMID 29495634›Full record

ArticleNanomaterials (Basel, Switzerland)2018

MOF-Derived Cu@Cu₂O Nanocatalyst for Oxygen Reduction Reaction and Cycloaddition Reaction.

Aram Kim, Nallal Muthuchamy, Chohye Yoon, Sang Hoon Joo, Kang Hyun Park

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nanostructured CuNanomaterials (Basel, Switzerland) · 2019
    Article
  8. Article
  9. Ligands-Coordinated Zr-Based MOF for Wastewater Treatment.Nanomaterials (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aram KimDepartment of Chemistry, Pusan National University, Busan 46241, Korea. aramchemi@gmail.com.
Nallal MuthuchamyDepartment of Chemistry, Pusan National University, Busan 46241, Korea. muthuchamyn89@gmail.com.ORCID 0000-0002-2298-6603
Chohye YoonDepartment of Chemistry, Pusan National University, Busan 46241, Korea. yoonch@chemistry.or.kr.
Sang Hoon JooSchool of Energy and Chemical Engineering, Ulsan National Institute of Science and Technology (UNIST), 50 UNIST-gil, Ulsan 44919, Korea. shjoo@unist.ac.kr.
Kang Hyun ParkDepartment of Chemistry, Pusan National University, Busan 46241, Korea. chemistry@pusan.ac.kr.ORCID 0000-0001-9946-0522
Pusan National University · KRUlsan National Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research on the synthesis of nanomaterials using metal-organic frameworks (MOFs), which are characterized by multi-functionality and porosity, as precursors have been accomplished through various synthetic approaches. In this study, copper and copper oxide nanoparticles were fabricated within 30 min by a simple and rapid method involving the reduction of a copper(II)-containing MOF with sodium borohydride solution at room temperature. The obtained nanoparticles consist of a copper core and a copper oxide shell exhibited catalytic activity in the oxygen reduction reaction. The as-synthesized Cu@Cu₂O core-shell nanocatalyst exhibited an enhanced limit current density as well as onset potential in the electrocatalytic oxygen reduction reaction (ORR). Moreover, the nanoparticles exhibited good catalytic activity in the Huisgen cycloaddition of various substituted azides and alkynes under mild reaction conditions.

Indexed as

Cu@Cu2OelectrocatalystHuisgen cycloadditionmetal-organic frameworknanocatalystoxygen reduction reaction

Identifiers

PMID29495634
PMCPMC5869629
OpenAlexW2792106289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.